Spectral Diagnostics to Present at BioFinance 2012
News May 21, 2012
Spectral Diagnostics Inc., has announced that Dr. Paul Walker, the Company's President and Chief Executive Officer, will present at BioFinance 2012 on Wednesday, May 30, at 9:20 a.m. Eastern Time.
The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Ontario.
Dr. Walker will provide a corporate update, including information about the Company's pivotal sepsis program.
BioFinance is a prominent Canadian investor conference for the life sciences industry.
The two-day event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector.
Presenting companies span a range of industries including biologics, medical devices, drug delivery, vaccines, and diagnostics.
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE
Fabric Genomics Partners to Improve Pediatric CareNews
Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.READ MORE
Edico Genome and Fabric Genomics Develop Integrated Solution for Genomics AnalysisNews
Industry leaders partner to provide streamlined variant data analysis solution, with the goal of improving clinical care.READ MORE